Gene symbol: Il18

Also known as: IL-18; IL-1 gamma

Organism: Rattus norvegicus

Summary: Predicted to enable cytokine activity and interleukin-18 receptor binding activity. Involved in several processes, including cellular response to hormone stimulus; positive regulation of cell population proliferation; and positive regulation of cytokine production. Located in apical plasma membrane; cytoplasm; and extracellular space. Used to study brain edema; fatty liver disease; heart disease; status epilepticus; and vasculitis. Biomarker of several diseases, including cardiac arrest; ischemia (multiple); lung disease (multiple); perinatal necrotizing enterocolitis; and urinary tract infection. Human ortholog(s) of this gene implicated in several diseases, including Kawasaki disease; allergic rhinitis; autoimmune disease (multiple); biliary atresia; and hepatitis B. Orthologous to human IL18 (interleukin 18). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 29197 Ensembl:ENSRNOG00000009848 AllianceGenome:RGD:2889


GO Annotation


Category Term ID Term description
Process GO:0000165 MAPK cascade
Process GO:0000302 Response to reactive oxygen species
Process GO:0001503 Ossification
Process GO:0001525 Angiogenesis
Process GO:0001568 Blood vessel development
Process GO:0001649 Osteoblast differentiation
Process GO:0001666 Response to hypoxia
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001889 Liver development
Process GO:0001906 Cell killing
Process GO:0001909 Leukocyte mediated cytotoxicity
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0002228 Natural killer cell mediated immunity
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0002250 Adaptive immune response
Process GO:0002252 Immune effector process
Process GO:0002274 Myeloid leukocyte activation
Process GO:0002376 Immune system process
Process GO:0002443 Leukocyte mediated immunity
Process GO:0002449 Lymphocyte mediated immunity
Process GO:0002460 Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002696 Positive regulation of leukocyte activation
Process GO:0002697 Regulation of immune effector process
Process GO:0002699 Positive regulation of immune effector process
Process GO:0002700 Regulation of production of molecular mediator of immune response
Process GO:0002702 Positive regulation of production of molecular mediator of immune response
Process GO:0002703 Regulation of leukocyte mediated immunity
Process GO:0002705 Positive regulation of leukocyte mediated immunity
Process GO:0002706 Regulation of lymphocyte mediated immunity
Process GO:0002708 Positive regulation of lymphocyte mediated immunity
Process GO:0002709 Regulation of T cell mediated immunity
Process GO:0002711 Positive regulation of T cell mediated immunity
Process GO:0002718 Regulation of cytokine production involved in immune response
Process GO:0002720 Positive regulation of cytokine production involved in immune response
Process GO:0002724 Regulation of T cell cytokine production
Process GO:0002726 Positive regulation of T cell cytokine production
Process GO:0002819 Regulation of adaptive immune response
Process GO:0002821 Positive regulation of adaptive immune response
Process GO:0002822 Regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002824 Positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002825 Regulation of T-helper 1 type immune response
Process GO:0002827 Positive regulation of T-helper 1 type immune response
Process GO:0002828 Regulation of type 2 immune response
Process GO:0002830 Positive regulation of type 2 immune response
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006954 Inflammatory response
Process GO:0006955 Immune response
Process GO:0006979 Response to oxidative stress
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007600 Sensory perception
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0008015 Blood circulation
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0009266 Response to temperature stimulus
Process GO:0009314 Response to radiation
Process GO:0009409 Response to cold
Process GO:0009581 Detection of external stimulus
Process GO:0009582 Detection of abiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009612 Response to mechanical stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010712 Regulation of collagen metabolic process
Process GO:0010714 Positive regulation of collagen metabolic process
Process GO:0010743 Regulation of macrophage derived foam cell differentiation
Process GO:0010744 Positive regulation of macrophage derived foam cell differentiation
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0014066 Regulation of phosphatidylinositol 3-kinase signaling
Process GO:0014068 Positive regulation of phosphatidylinositol 3-kinase signaling
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0014910 Regulation of smooth muscle cell migration
Process GO:0014911 Positive regulation of smooth muscle cell migration
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019221 Cytokine-mediated signaling pathway
Process GO:0019222 Regulation of metabolic process
Process GO:0019233 Sensory perception of pain
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022409 Positive regulation of cell-cell adhesion
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030101 Natural killer cell activation
Process GO:0030104 Water homeostasis
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030431 Sleep
Process GO:0031099 Regeneration
Process GO:0031100 Animal organ regeneration
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031347 Regulation of defense response
Process GO:0031349 Positive regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031663 Lipopolysaccharide-mediated signaling pathway
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032147 Activation of protein kinase activity
Process GO:0032148 Activation of protein kinase B activity
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032645 Regulation of granulocyte macrophage colony-stimulating factor production
Process GO:0032649 Regulation of interferon-gamma production
Process GO:0032651 Regulation of interleukin-1 beta production
Process GO:0032652 Regulation of interleukin-1 production
Process GO:0032660 Regulation of interleukin-17 production
Process GO:0032677 Regulation of interleukin-8 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032725 Positive regulation of granulocyte macrophage colony-stimulating factor production
Process GO:0032729 Positive regulation of interferon-gamma production
Process GO:0032731 Positive regulation of interleukin-1 beta production
Process GO:0032732 Positive regulation of interleukin-1 production
Process GO:0032740 Positive regulation of interleukin-17 production
Process GO:0032757 Positive regulation of interleukin-8 production
Process GO:0032760 Positive regulation of tumor necrosis factor production
Process GO:0032814 Regulation of natural killer cell activation
Process GO:0032816 Positive regulation of natural killer cell activation
Process GO:0032817 Regulation of natural killer cell proliferation
Process GO:0032819 Positive regulation of natural killer cell proliferation
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032928 Regulation of superoxide anion generation
Process GO:0032930 Positive regulation of superoxide anion generation
Process GO:0032944 Regulation of mononuclear cell proliferation
Process GO:0032946 Positive regulation of mononuclear cell proliferation
Process GO:0032965 Regulation of collagen biosynthetic process
Process GO:0032967 Positive regulation of collagen biosynthetic process
Process GO:0033029 Regulation of neutrophil apoptotic process
Process GO:0033030 Negative regulation of neutrophil apoptotic process
Process GO:0033032 Regulation of myeloid cell apoptotic process
Process GO:0033033 Negative regulation of myeloid cell apoptotic process
Process GO:0033554 Cellular response to stress
Process GO:0033561 Regulation of water loss via skin
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034103 Regulation of tissue remodeling
Process GO:0034105 Positive regulation of tissue remodeling
Process GO:0034341 Response to interferon-gamma
Process GO:0034599 Cellular response to oxidative stress
Process GO:0034612 Response to tumor necrosis factor
Process GO:0034614 Cellular response to reactive oxygen species
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0035655 interleukin-18-mediated signaling pathway
Process GO:0036230 Granulocyte activation
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036296 Response to increased oxygen levels
Process GO:0038061 NIK/NF-kappaB signaling
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042088 T-helper 1 type immune response
Process GO:0042102 Positive regulation of T cell proliferation
Process GO:0042104 Positive regulation of activated T cell proliferation
Process GO:0042119 Neutrophil activation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042129 Regulation of T cell proliferation
Process GO:0042221 Response to chemical
Process GO:0042267 Natural killer cell mediated cytotoxicity
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042509 Regulation of tyrosine phosphorylation of STAT protein
Process GO:0042531 Positive regulation of tyrosine phosphorylation of STAT protein
Process GO:0042542 Response to hydrogen peroxide
Process GO:0042592 Homeostatic process
Process GO:0042632 Cholesterol homeostasis
Process GO:0042742 Defense response to bacterium
Process GO:0042749 Regulation of circadian sleep/wake cycle
Process GO:0042752 Regulation of circadian rhythm
Process GO:0042981 Regulation of apoptotic process
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043114 Regulation of vascular permeability
Process GO:0043117 Positive regulation of vascular permeability
Process GO:0043207 Response to external biotic stimulus
Process GO:0043370 Regulation of CD4-positive, alpha-beta T cell differentiation
Process GO:0043372 Positive regulation of CD4-positive, alpha-beta T cell differentiation
Process GO:0043434 Response to peptide hormone
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043525 Positive regulation of neuron apoptotic process
Process GO:0043549 Regulation of kinase activity
Process GO:0043588 Skin development
Process GO:0044093 Positive regulation of molecular function
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045087 Innate immune response
Process GO:0045187 Regulation of circadian sleep/wake cycle, sleep
Process GO:0045188 Regulation of circadian sleep/wake cycle, non-REM sleep
Process GO:0045321 Leukocyte activation
Process GO:0045580 Regulation of T cell differentiation
Process GO:0045582 Positive regulation of T cell differentiation
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045619 Regulation of lymphocyte differentiation
Process GO:0045621 Positive regulation of lymphocyte differentiation
Process GO:0045622 Regulation of T-helper cell differentiation
Process GO:0045624 Positive regulation of T-helper cell differentiation
Process GO:0045628 Regulation of T-helper 2 cell differentiation
Process GO:0045630 Positive regulation of T-helper 2 cell differentiation
Process GO:0045661 Regulation of myoblast differentiation
Process GO:0045662 Negative regulation of myoblast differentiation
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046006 Regulation of activated T cell proliferation
Process GO:0046634 Regulation of alpha-beta T cell activation
Process GO:0046635 Positive regulation of alpha-beta T cell activation
Process GO:0046637 Regulation of alpha-beta T cell differentiation
Process GO:0046638 Positive regulation of alpha-beta T cell differentiation
Process GO:0046640 Regulation of alpha-beta T cell proliferation
Process GO:0046641 Positive regulation of alpha-beta T cell proliferation
Process GO:0046649 Lymphocyte activation
Process GO:0046683 Response to organophosphorus
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048546 Digestive tract morphogenesis
Process GO:0048565 Digestive tract development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048878 Chemical homeostasis
Process GO:0050670 Regulation of lymphocyte proliferation
Process GO:0050671 Positive regulation of lymphocyte proliferation
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050727 Regulation of inflammatory response
Process GO:0050729 Positive regulation of inflammatory response
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050732 Negative regulation of peptidyl-tyrosine phosphorylation
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050795 Regulation of behavior
Process GO:0050830 Defense response to Gram-positive bacterium
Process GO:0050863 Regulation of T cell activation
Process GO:0050865 Regulation of cell activation
Process GO:0050867 Positive regulation of cell activation
Process GO:0050870 Positive regulation of T cell activation
Process GO:0050877 Nervous system process
Process GO:0050878 Regulation of body fluid levels
Process GO:0050890 Cognition
Process GO:0050891 Multicellular organismal water homeostasis
Process GO:0050896 Response to stimulus
Process GO:0050906 Detection of stimulus involved in sensory perception
Process GO:0050954 Sensory perception of mechanical stimulus
Process GO:0050966 Detection of mechanical stimulus involved in sensory perception of pain
Process GO:0050974 Detection of mechanical stimulus involved in sensory perception
Process GO:0050982 Detection of mechanical stimulus
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051092 Positive regulation of NF-kappaB transcription factor activity
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051133 Regulation of NK T cell activation
Process GO:0051135 Positive regulation of NK T cell activation
Process GO:0051140 Regulation of NK T cell proliferation
Process GO:0051142 Positive regulation of NK T cell proliferation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051249 Regulation of lymphocyte activation
Process GO:0051251 Positive regulation of lymphocyte activation
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051591 Response to cAMP
Process GO:0051606 Detection of stimulus
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051897 Positive regulation of protein kinase B signaling
Process GO:0055088 Lipid homeostasis
Process GO:0055090 Acylglycerol homeostasis
Process GO:0055092 Sterol homeostasis
Process GO:0055093 Response to hyperoxia
Process GO:0055123 Digestive system development
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060312 Regulation of blood vessel remodeling
Process GO:0060541 Respiratory system development
Process GO:0060548 Negative regulation of cell death
Process GO:0061008 Hepaticobiliary system development
Process GO:0061436 Establishment of skin barrier
Process GO:0062149 Detection of stimulus involved in sensory perception of pain
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070301 Cellular response to hydrogen peroxide
Process GO:0070328 Triglyceride homeostasis
Process GO:0070482 Response to oxygen levels
Process GO:0070663 Regulation of leukocyte proliferation
Process GO:0070665 Positive regulation of leukocyte proliferation
Process GO:0070673 Response to interleukin-18
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071107 Response to parathyroid hormone
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071216 Cellular response to biotic stimulus
Process GO:0071219 Cellular response to molecule of bacterial origin
Process GO:0071222 Cellular response to lipopolysaccharide
Process GO:0071260 Cellular response to mechanical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071320 Cellular response to cAMP
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071346 Cellular response to interferon-gamma
Process GO:0071351 Cellular response to interleukin-18
Process GO:0071356 Cellular response to tumor necrosis factor
Process GO:0071374 Cellular response to parathyroid hormone stimulus
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071496 Cellular response to external stimulus
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090322 Regulation of superoxide metabolic process
Process GO:0097421 Liver regeneration
Process GO:0098542 Defense response to other organism
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0120161 Regulation of cold-induced thermogenesis
Process GO:0120162 Positive regulation of cold-induced thermogenesis
Process GO:1901214 Regulation of neuron death
Process GO:1901216 Positive regulation of neuron death
Process GO:1901222 Regulation of NIK/NF-kappaB signaling
Process GO:1901224 Positive regulation of NIK/NF-kappaB signaling
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902105 Regulation of leukocyte differentiation
Process GO:1902107 Positive regulation of leukocyte differentiation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903037 Regulation of leukocyte cell-cell adhesion
Process GO:1903039 Positive regulation of leukocyte cell-cell adhesion
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903557 Positive regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903706 Regulation of hemopoiesis
Process GO:1903708 Positive regulation of hemopoiesis
Process GO:1905936 Regulation of germ cell proliferation
Process GO:1905938 Positive regulation of germ cell proliferation
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000106 Regulation of leukocyte apoptotic process
Process GO:2000107 Negative regulation of leukocyte apoptotic process
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000241 Regulation of reproductive process
Process GO:2000243 Positive regulation of reproductive process
Process GO:2000254 Regulation of male germ cell proliferation
Process GO:2000256 Positive regulation of male germ cell proliferation
Process GO:2000345 Regulation of hepatocyte proliferation
Process GO:2000347 Positive regulation of hepatocyte proliferation
Process GO:2000377 Regulation of reactive oxygen species metabolic process
Process GO:2000379 Positive regulation of reactive oxygen species metabolic process
Process GO:2000504 Positive regulation of blood vessel remodeling
Process GO:2000514 Regulation of CD4-positive, alpha-beta T cell activation
Process GO:2000516 Positive regulation of CD4-positive, alpha-beta T cell activation
Process GO:2000554 Regulation of T-helper 1 cell cytokine production
Process GO:2000556 Positive regulation of T-helper 1 cell cytokine production
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005576 Extracellular region
Component GO:0005615 Extracellular space
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005886 Plasma membrane
Component GO:0016020 Membrane
Component GO:0016324 Apical plasma membrane
Component GO:0045177 Apical part of cell
Component GO:0071944 Cell periphery
Component GO:0098590 Plasma membrane region
Component GO:0110165 Cellular anatomical entity
Function GO:0005102 Signaling receptor binding
Function GO:0005125 Cytokine activity
Function GO:0005126 Cytokine receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0045515 interleukin-18 receptor binding
Function GO:0048018 Receptor ligand activity
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
KEGG rno04060 Cytokine-cytokine receptor interaction
KEGG rno04061 Viral protein interaction with cytokine and cytokine receptor
KEGG rno04621 NOD-like receptor signaling pathway
KEGG rno04623 Cytosolic DNA-sensing pathway
KEGG rno05132 Salmonella infection
KEGG rno05134 Legionellosis
KEGG rno05135 Yersinia infection
KEGG rno05143 African trypanosomiasis
KEGG rno05144 Malaria
KEGG rno05152 Tuberculosis
KEGG rno05164 Influenza A
KEGG rno05321 Inflammatory bowel disease
KEGG rno05323 Rheumatoid arthritis
KEGG rno05417 Lipid and atherosclerosis

Expression profile of Il18 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 9.680267
GSM2685202 MX2 tissue: Myocardium gender: female 8.308795
GSM2685203 MX3 tissue: Myocardium gender: female 8.560282
GSM2685204 MX4 tissue: Myocardium gender: male 7.4961276
GSM2685205 DZ1 tissue: Myocardium gender: male 9.134377
GSM2685206 DZ2 tissue: Myocardium gender: male 8.847688
GSM2685207 DZ3 tissue: Myocardium gender: female 8.075088
GSM2685208 DZ4 tissue: Myocardium gender: female 8.812081
GSM2685209 JJ1 tissue: Myocardium gender: male 7.571175
GSM2685210 JJ2 tissue: Myocardium gender: female 7.790145
GSM2685211 JJ3 tissue: Myocardium gender: female 7.6975093
GSM2685212 JJ4 tissue: Myocardium gender: male 8.720022
GSM2685213 NG1 tissue: Myocardium gender: male 8.263992
GSM2685214 NG2 tissue: Myocardium gender: female 9.363262
GSM2685215 NG3 tissue: Myocardium gender: male 9.113556
GSM2685216 NG4 tissue: Myocardium gender: female 8.7418375
GSM2685217 YL1 tissue: Myocardium gender: male 8.2854
GSM2685218 YL2 tissue: Myocardium gender: male 8.4751
GSM2685219 YL3 tissue: Myocardium gender: female 7.697862
GSM2685220 YL4 tissue: Myocardium gender: female 8.18997
GSM2685221 QC1 tissue: Myocardium gender: male 8.728447
GSM2685222 QC2 tissue: Myocardium gender: male 8.597372
GSM2685223 QC3 tissue: Myocardium gender: female 8.876286
GSM2685224 QC4 tissue: Myocardium gender: female 8.311368

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.242670848
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.195836789
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.3274589145
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.147803707
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.8704586814999997
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.9805389735

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 68.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 45.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 51.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 94.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 52.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 56.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 87.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 141.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 33.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 45.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 67.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 85.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 47.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 57.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 82.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 89.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.3155975
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.025705500000001
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.085072500000001
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.989584499999999
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.207776
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.4044265

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 15.236
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 15.556
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 15.646
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 9.733
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 11.805

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.068298407
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.243645382
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.145934045

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 69.95
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 11.549999999999999
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 35.95
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 29.75
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 41.2
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 34.65
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 26.049999999999997
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 71.8
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 32.55
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 45.0
GSM27494 CTL_a (control, 1st replicate) 69.55000000000001
GSM27495 CTL_b (control, 2nd replicate) 52.650000000000006
GSM27496 CTL_c (control, 3rd replicate) 11.8
GSM27497 CTL_d (control, 4th replicate) 33.6
GSM27498 CTL_e (control, 5th replicate) 21.75
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 32.05
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 48.45
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 50.75
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 47.45
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 44.9
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 82.6
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 104.75
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 72.60000000000001
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 53.449999999999996
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 26.1
GSM27509 ISCH_a (ischemia, 1st replicate) 24.5
GSM27510 ISCH_b (ischemia, 2nd replicate) 49.2
GSM27511 ISCH_c (ischemia, 3rd replicate) 16.9
GSM27512 ISCH_d (ischemia, 4th replicate) 43.2
GSM27513 ISCH_e (ischemia, 5th replicate) 15.05

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 241.8
GSM30791 baseline control 02 male, 275-300g 144.7
GSM30792 baseline control 03 male, 275-300g 167.5
GSM30793 baseline control 04 male, 275-300g 172.4
GSM30794 baseline control 05 male, 275-300g 168.6
GSM30795 baseline control 06 male, 275-300g 136.1
GSM30796 baseline control 07 male, 275-300g 149.5
GSM30797 baseline control 08 male, 275-300g 191.7
GSM30798 baseline control 09 male, 275-300g 175.2
GSM30799 pain 01 271.2
GSM30800 pain 02 181.9
GSM30801 pain 03 295.1
GSM30802 pain 04 124.3
GSM30803 pain 05 166.8
GSM30804 FC 01 194.6
GSM30805 FC 02 232.7
GSM30806 FC 03 153.6
GSM30807 FC 04 167.7
GSM30808 FC 05 200.3
GSM30809 IFC 01 208.5
GSM30810 IFC 02 167.6
GSM30811 IFC 03 263.5
GSM30812 IFC 04 130.3
GSM30813 IFC 05 219.1
GSM99800 isoflurane 01 male, 275-300g 139.0
GSM99801 isoflurane 02 male, 275-300g 194.7
GSM99802 isoflurane 03 male, 275-300g 223.1
GSM99803 isoflurane 04 male, 275-300g 203.9
GSM99804 isoflurane 05 male, 275-300g 134.5

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 23.6831
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 86.8449
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 422.4145
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 198.1202
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 188.9492
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 231.4492
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 135.2814
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 181.258
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 55.8034

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 9.24635
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 9.70441
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 11.2666
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 10.8721
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 6.61146
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 7.39982
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 6.52744
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 6.61624
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 9.21295
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 8.80966
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 11.2598
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 11.5003
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 6.47372
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 7.28851
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 6.59527
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 6.74336

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.937258
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.987058
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.051765
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.723568
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.838128
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.620152
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.540768
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.802633
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.590623
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.755221
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.855623
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.610766
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.792745
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.52771
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.695161
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.465296
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.853599
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.612709
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.691189
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.470516
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.869392
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.102911
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.164224
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.931007
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.959471
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.740921
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.937705
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.721902
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.514085
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.708428
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.048952
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.331128
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.548288
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.613157
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.799583
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.813156
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.670756
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.895649
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.863006
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.116834
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.996201
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.840209
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.187694
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.324807
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.114766

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 5.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 15.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 4.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 9.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 8.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 6.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 7.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 9.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 8.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 11.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 9.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 15.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 7.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 12.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 10.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 8.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 12.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 16.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 15.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 12.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 3.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 13.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 7.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 14.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 14.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 9.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 13.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 9.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 2.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 12.541531
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 5.924043
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 7.422169
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 9.199276

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0109
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.028
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0612
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.483
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.0398
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0325
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0241
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.177
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.153
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.342
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.000396
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.218

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 11.15
GSM5121 Isoflurane single exposure control-2 19.2
GSM5122 Isoflurane single exposure control-3 15.7
GSM5124 Isoflurane single exposure 1 hr-1 38.449999999999996
GSM5126 Isoflurane single exposure 1 hr-2 10.15
GSM5127 Isoflurane single exposure 2 hr-1 33.599999999999994
GSM5130 Isoflurane single exposure 2 hr-2 25.200000000000003
GSM5131 Isoflurane single exposure 2 hr-3 19.9

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.251016296
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.047838677
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 7.121180277
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.924022226
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.578751756
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.620588054
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.641151474
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.965969037
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.484365136
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.993233161
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.110480505
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 7.702647088
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.086005878
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.701145267
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.153303228
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.214671106
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.253891533
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.012538488
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.302970714
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.267450561
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.132114028
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 7.985978873
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.421027243
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.297768117

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.302304
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.302304
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.539229
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.38422
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.354823
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.264447
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.242122
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.428449
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.449952
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.393172
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.371967
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.543817
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.270292
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.340531
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.59535
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.29589
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.40795
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.337884
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.456612
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.087457
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.256365
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.423464
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.568821
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.222478

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 137.1586
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 174.5742

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 516.095072
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1041.635088
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 780.6108505
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 682.453537
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 530.7815567
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 711.5464416
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 645.6844636
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1083.171635
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 535.9655732
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1081.385246
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1052.798607
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 596.6240215
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 625.326579
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1872.262536

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.251016296
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.047838677
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 7.121180277
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.924022226
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.578751756
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.620588054
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.641151474
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.965969037
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.484365136
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.993233161
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.110480505
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 7.702647088
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.086005878
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.701145267
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.153303228
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.214671106
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.253891533
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.012538488
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.302970714
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.267450561
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.132114028
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 7.985978873
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.421027243
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.297768117
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 516.095072
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1041.635088
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 780.6108505
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 682.453537
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 530.7815567
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 711.5464416
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 645.6844636
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1083.171635
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 535.9655732
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1081.385246
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1052.798607
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 596.6240215
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 625.326579
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1872.262536

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 29.650000000000002
GSM5084 Control 2 33.0
GSM5085 Control 3 41.75
GSM5086 Control 4 34.55
GSM5087 Control 5 32.7
GSM5090 Control 6 32.349999999999994
GSM5105 Control 7 34.0
GSM5106 Control 8 37.45
GSM5107 Control 9 26.950000000000003
GSM5108 Halothane 10 exposure-1 32.8
GSM5109 Halothane 10 exposures-2 33.25
GSM5110 Halothane 10 exposures-3 31.2
GSM5111 Halothane 5 exposures-1 30.4
GSM5112 Halothane 5 exposures-2 32.35
GSM5113 Halothane 5 exposures-3 26.05
GSM5114 Isoflurane 10 exposures-1 35.0
GSM5115 Isoflurane 10 exposures-2 50.55
GSM5116 Isoflurane 10 exposures-3 18.1
GSM5117 Isoflurane 5 exposures-1 30.95
GSM5118 Isoflurane 5 exposures-2 43.099999999999994
GSM5119 Isoflurane 5 exposures-3 23.8
GSM11379 Control 10 28.0
GSM11380 Control 11 31.700000000000003
GSM11381 Control 12 19.05

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 58.191
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 53.9865